Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28,412,394
-
Total 13F shares
-
26,254,849
-
Share change
-
-348,602
-
Total reported value
-
$609,261,942
-
Put/Call ratio
-
68%
-
Price per share
-
$23.21
-
Number of holders
-
163
-
Value change
-
-$9,219,231
-
Number of buys
-
77
-
Number of sells
-
78
Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q3 2024
As of 30 Sep 2024,
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,254,849 shares.
The largest 10 holders included
FEDERATED HERMES, INC., BlackRock, Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., ARK Investment Management LLC, VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Woodline Partners LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
163
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.